Diabetes Studies

Division of Endocrinology and Metabolism

Examine Study

For this study, we are recruiting patients who have type 2 diabetes and a recent acute coronary syndrome (ACS). The study is testing the long term safety and efficacy of alogliptin, a promising new medication for type 2 diabetes.

If interested in participating or for patient referral, call Eileen Pelayo, RM at 202-444-5014.